Latest article
U.S. FDA declines to approve Provention Bio’s diabetes drug
(Reuters) - The U.S. Food and Drug Administration on Tuesday rejected Prevention Bio Inc.'s approval of the experimental diabetes drug teplizumab, citing insufficient data,...
Tandem Diabetes Care Inc. (TNDM) Soars 1.72% on January 19
Market overview
consequences
Tandem Diabetes Care Inc. is a medical device company that develops products for people with insulin-dependent diabetes. The company has...
Insightful ideas and wholesome recipes to assist kids take care of examination stress
The year is drawing to a close and the holidays are just around the corner, but many anxious students still have exams to come....